OIS@AAO 2017 Videos
In addition to bringing us up to date on Aerie Pharmaceuticals’ progress, Thomas A. Mitro, president and COO, sheds some light on his path to…Read More
Chuck Hess, vice president and general manager at Bausch + Lomb, updates us on the company’s growing Stellaris Elite and Vitesse platforms as well as…Read More
Yari Mitchell, vice president of medical affairs and business strategy at AcuFocus, updates OIS.TV on the progress of the Kamra Inlay and the promise of…Read More
Dave Van Meter, president and CEO of Ivantis, explains how the company’s Hydrus Microstent plans to grab a piece of the growing MIGS market. He…Read More
Thomas Frinzi, worldwide president, surgical, Johnson & Johnson Vision, shares some impressive milestones for the company’s Symfony and Symfony Toric IOLs. He also discusses the…Read More
Few can track the past 10 years of advances in glaucoma treatment as well as Andrew Iwach, MD, executive director of the Glaucoma Center of…Read More
Dan Myers, CEO of Alimera Sciences, says company growth is moving the firm into cash-positive territory in 2018. What challenges did he have to conquer…Read More
Christian Roesky, PhD, CEO and managing director of Novaliq GmbH, explains how the company’s water-free ophthalmic therapies can bring new treatments to ophthalmology’s most vexing…Read More
Joe Boorady, OD, president & CEO of TearScience, details the rollout of the company’s dry eye suite of tools now that it’s part of Johnson…Read More
Tom Gadek, president and CEO of dry eye start-up TearSolutions, explains how his “religious vision quest” at SARcode Bioscience, the entity that developed the drug…Read More
Iconic Therapeutics is looking to take a significant step in ophthalmology in 2018, William Greene, MD, CEO, said during the Company Showcase 3 session at…Read More
Jonathan Norris, managing director at Silicon Valley Bank, points to increased fund-raising by healthcare-focused venture capital firms and a surge by strategic investors in Series…Read More
SUBSCRIBE TO OIS NEWS
Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.
We respect your privacy and promise to never send you spam.